Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland

Míreanna comhchosúla

• Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland
  de réir: Kristiana Alexandrova Nikolova, et al.
  Foilsithe / Cruthaithe: (2024-02-01)
• EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
  de réir: Ralf Rene Reinert, et al.
  Foilsithe / Cruthaithe: (2012-06-01)
• A decade of 10-valent pneumococcal conjugate vaccine use in Lithuania: trends in invasive pneumococcal serotype dynamics
  de réir: Aurelija Petrutienė, et al.
  Foilsithe / Cruthaithe: (2025-08-01)
• Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old
  de réir: Juan Buades, et al.
  Foilsithe / Cruthaithe: (2021-01-01)
• Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions
  de réir: Jeffrey Vietri, et al.
  Foilsithe / Cruthaithe: (2020-01-01)